1268865-09-3

Basic information

• Product Name: methyl 3-bromo-2-phenylquinoxaline-6-carboxylate
• Synonyms: methyl 3-bromo-2-phenylquinoxaline-6-carboxylate
• CAS NO: 1268865-09-3
• Molecular Weight: 343.18
• Mol File: 1268865-09-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: methyl 3-bromo-2-phenylquinoxaline-6-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-bromo-2-phenylquinoxaline-6-carboxylate(1268865-09-3)
• EPA Substance Registry System: methyl 3-bromo-2-phenylquinoxaline-6-carboxylate(1268865-09-3)

Safety Data

• Hazardous Substances Data: 1268865-09-3(Hazardous Substances Data)

Upstream product

• 403-21-4 3-fluoro-4-nitrobenzoic acid 
• 185629-31-6 methyl 3-fluoro-4-nitrobenzoate 
• 15028-40-7 DL-2-phenylglycine methyl ester hydrochloride 
• 23121-25-7 methyl 3-oxo-2-phenyl-1,2,3,4-tetrahydroquinoxaline-6-carboxylate 
• 1268865-04-8 methyl 4-((2-methoxy-2-oxo-1-phenylethyl)amino)-3-nitrobenzoate 
• 453-71-4 3-nitro-4-fluorobenzoic acid 
• 329-59-9 4-fluoro-3-nitro-benzoic acid methyl ester 

Downstream Products

• 1268865-29-7 methyl 3-(4-(4-chlorophenyl)piperazin-1-yl)-2-phenylquinoxaline-6-carboxylate 
• 1268865-37-7 methyl 3-(4-(4-methoxyphenyl)piperidin-1-yl)-2-phenylquinoxaline-6-carboxylate 
• 1268866-30-3 (S)-methyl 3-(3-hydroxypyrrolidin-1-yl)-2-phenylquinoxaline-6-carboxylate 
• 1268865-49-1 methyl 3-(isopropylamino)-2-phenylquinoxaline-6-carboxylate 
• 1268866-26-7 methyl 3-(sec-butylamino)-2-phenylquinoxaline-6-carboxylate 
• 1268865-99-1 methyl 3-(4-(tert-butoxycarbonyl)piperidin-1-yl)-2-phenylquinoxaline-6-carboxylate 
• 1268865-55-9 methyl 3-(4-(isoquinolin-3-yl)piperazin-1-yl)-2-phenylquinoxaline-6-carboxylate 
• 1268865-21-9 methyl 2-phenyl-3-(piperazin-1-yl)quinoxaline-6-carboxylate 
• 1268865-17-3 methyl 3-(4-(3-chlorophenyl)piperazin-1-yl)-2-phenylquinoxaline-6-carboxylate 
• 1268865-11-7 methyl 2-phenyl-3-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)quinoxaline-6-carboxylate 
• 1268865-26-4 methyl 2-phenyl-3-(4-(4-(trifluoromethyl)phenyl)piperidin-1-yl)quinoxaline-6-carboxylate 
• 1268866-28-9 (R)-methyl 3-(3-hydroxypyrrolidin-1-yl)-2-phenylquinoxaline-6-carboxylate 
• 1268866-63-2 (R)-methyl 3-(sec-butylamino)-2-phenylquinoxaline-6-carboxylate 
• 1268862-61-8 2-phenyl-3-(4-(pyrimidin-2-yl)piperazin-1-yl)quinoxaline-6-carboxylic acid 

Relevant articles and documents

QUINOXALINE COMPOUNDS AND USES THEREOF

This invention provides compounds of formula I and subsets thereof: wherein T, J, R, R4, Rq, o, RA, and RB and subsets thereof are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, or T-cell mediated autoimmune disease.

HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.